Literature DB >> 20723102

Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.

Annalisa Blasetti1, Concetta Di Giulio, Anna Maria Tocco, Alberto Verrotti, Stefano Tumini, Francesco Chiarelli, Emma Altobelli.   

Abstract

OBJECTIVE: Hypoglycemia remains a central problem in the management of type 1 diabetes mellitus (T1DM) and limits the achievement of good or normal glycemic control. The Diabetes Control and Complication Trial showed that intensive treatment of T1DM increased the risk of severe hypoglycemia (SH) when compared to conventional therapy. The aim of our study was to determine the incidence of SH and associated variables in a population of children and adolescents with T1DM. RESEARCH DESIGN AND METHODS: We performed a 7.5-yr prospective study enrolling 195 patients aged 13.9 ± 6.6 yr. The study was carried out by referring to the T1DM population-based register in the Abruzzo region of Italy. The incidence of SH, defined as blood glucose levels <50 mg/dL (<2.77 mmol/L) associated with altered states of consciousness (including confusional state, seizures, and coma) was recorded. Glycated hemoglobin (HbA1c) percentage, insulin dose, insulin regimen, time since diagnosis, and age at onset were also recorded.
RESULTS: One hundred and thirty-three severe hypoglycemic events occurred during the study period; the overall incidence was 9.4 episodes per 100 patient-years. Significant predictors of hypoglycemia were diabetes duration >10 yr (p = 0.01), basal/bolus insulin ratio (ratio of daily basal insulin units to daily bolus insulin units) >0.8 (p = 0.01). No relationship was found between hypoglycemic episodes and HbA1c levels, daily insulin requirements, or insulin regimen.
CONCLUSIONS: In these patients, a relatively low incidence of SH was recorded, without pronounced association with lower HbA1c or multiple daily injection insulin therapy. SH seems to be mainly related to management of diabetes. We believe that the main path to SH prevention is through patient and family education in the management of T1DM.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723102     DOI: 10.1111/j.1399-5448.2010.00655.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  10 in total

1.  Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases.

Authors:  Aveni Haynes; Julia M Hermann; Kellee M Miller; Sabine E Hofer; Timothy W Jones; Roy W Beck; David M Maahs; Elizabeth A Davis; Reinhard W Holl
Journal:  Pediatr Diabetes       Date:  2016-11-23       Impact factor: 4.866

2.  Recurrent moderate hypoglycemia exacerbates oxidative damage and neuronal death leading to cognitive dysfunction after the hypoglycemic coma.

Authors:  Gabriela Languren; Teresa Montiel; Leticia Ramírez-Lugo; Israela Balderas; Gustavo Sánchez-Chávez; Francisco Sotres-Bayón; Federico Bermúdez-Rattoni; Lourdes Massieu
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-19       Impact factor: 6.200

3.  Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.

Authors:  Ram Weiss; Satish K Garg; Richard M Bergenstal; David C Klonoff; Bruce W Bode; Timothy S Bailey; James Thrasher; Frank Schwartz; John B Welsh; Francine R Kaufman
Journal:  J Diabetes Sci Technol       Date:  2015-05-18

4.  Severe hypoglycemic episodes: a persistent threat for children with Type 1 diabetes mellitus and their families.

Authors:  G Maltoni; S Zucchini; M Scipione; A Rollo; C Balsamo; C Bertolini; F Baronio; R Rondelli; A Pession
Journal:  J Endocrinol Invest       Date:  2013-03-19       Impact factor: 4.256

5.  Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study.

Authors:  Damla Gökşen Simsek; Zehra Aycan; Samim Özen; Semra Cetinkaya; Cengiz Kara; Saygın Abalı; Korcan Demir; Ozgül Tunç; Ahmet Uçaktürk; Gülgün Asar; Firdevs Baş; Ergun Cetinkaya; Murat Aydın; Gülay Karagüzel; Zerrin Orbak; Zeynep Sıklar; Ayça Altıncık; Ayşenur Ökten; Behzat Özkan; Gönül Ocal; Serap Semiz; İlknur Arslanoğlu; Olcay Evliyaoğlu; Rüveyde Bundak; Şükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-02-19

6.  Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality.

Authors:  Margaret Maheandiran; Shanthini Mylvaganam; Chiping Wu; Youssef El-Hayek; Sonia Sugumar; Lili Hazrati; Martin del Campo; Adria Giacca; Liang Zhang; Peter L Carlen
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

7.  Empowerment-Based Diabetes Self-Management Education to Maintain Glycemic Targets During Ramadan Fasting in People With Diabetes Who Are on Conventional Insulin: A Feasibility Study.

Authors:  Yara M Eid; Sahar I Sahmoud; Mona M Abdelsalam; Barbara Eichorst
Journal:  Diabetes Spectr       Date:  2017-02

8.  Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial.

Authors:  Anissa Messaaoui; Sylvie Tenoutasse; Lucia Hajselova; Laurent Crenier
Journal:  Diabetes Ther       Date:  2022-07-23       Impact factor: 3.595

9.  Children's and adolescent's self - assessment of metabolic control versus professional judgment: a cross-sectional retrospective and prospective cohort study.

Authors:  Andreas Bieri; Monika Oser-Meier; Marco Janner; Chantal Cripe-Mamie; Kathrin Pipczynski-Suter; Primus E Mullis; Christa E Flück
Journal:  Int J Pediatr Endocrinol       Date:  2013-12-17

10.  Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012.

Authors:  Beate Karges; Joachim Rosenbauer; Thomas Kapellen; Verena M Wagner; Edith Schober; Wolfram Karges; Reinhard W Holl
Journal:  PLoS Med       Date:  2014-10-07       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.